In addition, we show that the dual PI3K-mTOR inhibitor NVP-BEZ235 (also known as dactolisib) reduces the cell viability of ICR-SS-1 and the two other synovial sarcoma cell lines. The gene discussed is MTOR; the disease is synovial sarcoma.